| Phase 15 trials |
|
Phase 1
|
NCT01298401 |
Feb 2012 → Nov 2013 |
malignant pancreatic neoplasm |
Radiation Therapy Oncology Group |
Completed
|
No outcome recorded
|
|
Phase 1
|
NCT01122199 |
May 2010 → Jan 2015 |
metastatic neoplasm |
Shadia Jalal |
Completed
|
No outcome recorded
|
|
Phase 1
|
NCT01061788 |
Apr 2010 → Dec 2018 |
non-small cell lung carcinoma |
Jeffrey Clarke |
Completed
|
No outcome recorded
|
|
Phase 1
|
NCT00974896 |
Dec 2006 → Sep 2010 |
cancer |
NantCell, Inc. |
Completed
|
No outcome recorded
|
|
Phase 1
|
NCT00562380 |
Oct 2005 → Apr 2010 |
cancer of unknown primary site, lymphoma, prostate cancer, sarcoma +1 |
Amgen |
Completed
|
No outcome recorded
|
| Phase 1/29 trials |
|
Phase 1/2
|
NCT03041701 |
Jul 2017 → Sep 2021 |
alveolar rhabdomyosarcoma, embryonal rhabdomyosarcoma |
National Cancer Institute (NCI) |
Terminated
|
No outcome recorded
|
|
Phase 1/2
|
NCT01708161 |
Nov 2012 → Dec 2014 |
— |
Novartis Pharmaceuticals |
Terminated
|
No outcome recorded
|
|
Phase 1/2
|
NCT01479179 |
Nov 2012 → Nov 2015 |
breast cancer |
M.D. Anderson Cancer Center |
Withdrawn
|
No outcome recorded
|
|
Phase 1/2
|
NCT01562899 |
Aug 2012 → Apr 2015 |
pancreatic adenocarcinoma |
Pfizer |
Terminated
|
No outcome recorded
|
|
Phase 1/2
|
NCT01473303 |
Aug 2012 |
pancreatic ductal adenocarcinoma |
Alliance for Clinical Trials in Oncology |
Withdrawn
|
No outcome recorded
|
|
Phase 1/2
|
NCT00807612 |
Jan 2009 → Aug 2010 |
non-small cell squamous lung carcinoma |
NantCell, Inc. |
Terminated
|
No outcome recorded
|
|
Phase 1/2
|
NCT00791154 |
Dec 2008 → Feb 2010 |
small cell lung carcinoma |
NantCell, Inc. |
Terminated
|
No outcome recorded
|
|
Phase 1/2
|
NCT00788957 |
Oct 2008 → Jul 2010 |
colon carcinoma, rectal cancer |
NantBioScience, Inc. |
Completed
|
No outcome recorded
|
|
Phase 1/2
|
NCT00630552 |
Jun 2007 → Jan 2010 |
pancreatic adenocarcinoma |
NantCell, Inc. |
Completed
|
No outcome recorded
|
| Phase 210 trials |
|
Phase 2
|
NCT04129151 |
Dec 2019 → Dec 2022 |
Ewing sarcoma |
Dana-Farber Cancer Institute |
Terminated
|
No outcome recorded
|
|
Phase 2
|
NCT01318642 |
May → Nov 2012 |
pancreatic adenocarcinoma |
NantBioScience, Inc. |
Terminated
|
No outcome recorded
|
|
Phase 2
|
NCT01327612 |
Mar 2011 → Feb 2020 |
carcinoid tumor, colorectal cancer, lymphoma, metastatic malignant neoplasm +2 |
Amgen |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT01042379 |
Mar 2010 → Dec 2030 expected |
HER2 positive breast carcinoma, angiosarcoma, female breast carcinoma, hormone receptor-positive breast cancer +1 |
QuantumLeap Healthcare Collaborative |
Recruiting
|
No outcome recorded
|
|
Phase 2
|
NCT01024387 |
Mar 2010 → Jan 2016 |
carcinoid tumor, pancreatic neuroendocrine tumor |
Dana-Farber Cancer Institute |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT00891930 |
May 2009 → Jul 2013 |
colorectal cancer |
NantBioScience, Inc. |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT00813605 |
Mar 2009 → Jan 2011 |
colorectal cancer |
NantCell, Inc. |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT00719212 |
Jan 2009 → May 2013 |
ovarian neoplasm |
Translational Research in Oncology |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT00718523 |
Jan 2009 → Sep 2013 |
ovarian neoplasm |
Translational Research in Oncology |
Terminated
|
No outcome recorded
|
|
Phase 2
|
NCT00563680 |
Oct 2007 → Aug 2009 |
Askin tumor, desmoplastic small round cell tumor, extraskeletal Ewing sarcoma |
NantCell, Inc. |
Completed
|
No outcome recorded
|
| Phase 32 trials |
|
Phase 3
|
NCT02306161 |
Dec 2014 → Mar 2021 overdue |
Ewing sarcoma, bone marrow cancer, metastatic malignant neoplasm, peripheral primitive neuroectodermal tumor of bone +1 |
National Cancer Institute (NCI) |
Active not recruiting
|
No outcome recorded
|
|
Phase 3
|
NCT01231347 |
Apr 2011 → Dec 2012 |
malignant endocrine neoplasm, metastatic carcinoma in the bone, pancreatic adenocarcinoma |
NantCell, Inc. |
Completed
|
No outcome recorded
|
| Phase not applicable1 trial |
| — |
NCT04199026 |
Feb 2025 → Dec 2028 expected |
sarcoma |
M.D. Anderson Cancer Center |
Recruiting
|
No outcome recorded
|
| Phase not stated1 trial |
| — |
NCT03029481 |
— |
Ewing sarcoma |
Jonsson Comprehensive Cancer Center |
No longer available
|
No outcome recorded
|